Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 31, 2022

SELL
$198.88 - $227.6 $492,824 - $563,992
-2,478 Closed
0 $0
Q3 2021

Oct 29, 2021

SELL
$212.27 - $248.7 $3.98 Million - $4.67 Million
-18,769 Reduced 88.34%
2,478 $527,000
Q2 2021

Jul 30, 2021

SELL
$233.58 - $259.14 $1.07 Million - $1.19 Million
-4,584 Reduced 17.75%
21,247 $5.18 Million
Q1 2021

May 07, 2021

BUY
$221.91 - $258.6 $39,499 - $46,030
178 Added 0.69%
25,831 $6.43 Million
Q4 2020

Feb 05, 2021

SELL
$216.38 - $257.67 $19,257 - $22,932
-89 Reduced 0.35%
25,653 $5.9 Million
Q3 2020

Oct 27, 2020

SELL
$234.65 - $260.95 $13,609 - $15,135
-58 Reduced 0.22%
25,742 $6.54 Million
Q2 2020

Aug 04, 2020

SELL
$197.81 - $242.74 $36,792 - $45,149
-186 Reduced 0.72%
25,800 $6.09 Million
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $512,458 - $679,660
-2,812 Reduced 9.76%
25,986 $5.27 Million
Q4 2019

Feb 04, 2020

BUY
$189.21 - $243.2 $93,848 - $120,627
496 Added 1.75%
28,798 $6.94 Million
Q3 2019

Oct 24, 2019

SELL
$174.11 - $208.62 $435,275 - $521,550
-2,500 Reduced 8.12%
28,302 $5.48 Million
Q2 2019

Jul 15, 2019

BUY
$166.7 - $195.41 $132,193 - $154,960
793 Added 2.64%
30,802 $5.68 Million
Q1 2019

Apr 23, 2019

BUY
$180.87 - $203.88 $975,251 - $1.1 Million
5,392 Added 21.9%
30,009 $5.7 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $36,393 - $42,483
-204 Reduced 0.82%
24,617 $4.79 Million
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $22,049 - $24,857
119 Added 0.48%
24,821 $5.15 Million
Q2 2018

Jul 16, 2018

SELL
$166.05 - $186.51 $348,372 - $391,297
-2,098 Reduced 7.83%
24,702 $4.56 Million
Q1 2018

Apr 27, 2018

BUY
$169.43 - $198.0 $17,112 - $19,998
101 Added 0.38%
26,800 $4.57 Million
Q4 2017

Jan 25, 2018

SELL
$168.79 - $188.59 $199,340 - $222,724
-1,181 Reduced 4.24%
26,699 $4.64 Million
Q3 2017

Nov 15, 2017

BUY
$167.29 - $191.0 $85,317 - $97,410
510 Added 1.86%
27,880 $5.2 Million
Q2 2017

Aug 10, 2017

BUY
N/A
27,370
27,370 $4.71 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Carderock Capital Management Inc Portfolio

Follow Carderock Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carderock Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Carderock Capital Management Inc with notifications on news.